P2RX1 and leukemia: Interestingly, we showed that P2X1 knockdown in several human primary leukemia cell lines from other FAB-AML types also led to a significant delay in cell proliferation, indicating that P2X1 may exert its oncogenic effects on a variety of cancer types.